文献速递淋巴瘤

基于欧洲人群的多基因风险评分与全基因组关联研究:以色列犹太人与巴勒斯坦阿拉伯人的B细胞非霍奇金淋巴瘤亚型

European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs.
PubMed 文献 · Br J Haematol · 2025-08-31

在以色列犹太人(IJ)和巴勒斯坦阿拉伯人(PA)中评估基于欧洲祖先(EA)已确立SNP的亚型特异性多基因风险评分(PRS),并对合并族群进行GWAS以发现新位点。共纳入752例IJ(201例DLBCL、130例FL、54例MZL、367例对照)和593例PA(203例DLBCL、41例FL、349例对照)。合并族群中,亚型特异性PRS与相应亚型显著相关,DLBCL、FL和MZL风险分别为1.69倍、2.21倍和2.26倍,但效应量较EA报告减弱且随族群而异;GWAS在6p21.32位点发现两个与DLBCL风险相关的新SNP。

要点

  • 在IJ和PA合并族群中,基于EA-SNP的亚型特异性PRS与DLBCL、FL、MZL风险显著相关,风险分别为1.69倍、2.21倍和2.26倍。
  • 上述PRS效应量较EA人群报道减弱,且随族群不同而变化。
  • 合并族群GWAS在6p21.32位点发现两个与DLBCL风险相关的新SNP。

核心结论

  • 在IJ和PA合并族群中,基于EA-SNP的亚型特异性PRS与DLBCL、FL和MZL风险显著相关,风险分别为1.69倍、2.21倍和2.26倍,但效应量较EA报道减弱且随族群而异。
  • 合并族群GWAS在6p21.32位点发现两个与DLBCL风险相关的新SNP。
  • 需要在犹太人和阿拉伯人群中开展更多GWAS研究以改善这些族群的NHL遗传风险预测。

研究设计与样本

  • 基于EA已确立SNP评估亚型特异性PRS,并在IJ和PA合并族群中进行GWAS以发现新位点。
  • 纳入三种常见病理确诊亚型:弥漫性大B细胞淋巴瘤(DLBCL)、滤泡性淋巴瘤(FL)和边缘区淋巴瘤(MZL)。
  • 对照按年龄和性别与病例进行频率匹配。
  • 纳入752例IJ(201例DLBCL、130例FL、54例MZL、367例对照)和593例PA(203例DLBCL、41例FL、349例对照)。
  • PRS以EA来源的效应估计值加权,并使用校正混杂因素的logistic回归模型分析。

主要发现

  • 在IJ和PA合并族群中,亚型特异性PRS与相应亚型显著相关:DLBCL风险为1.69倍、FL为2.21倍、MZL为2.26倍。
  • 上述PRS效应量较EA人群报道减弱,且随族群不同而变化。
  • 合并族群GWAS中,6p21.32位点的两个新SNP与DLBCL风险相关。

关键数值与推荐

  • DLBCL的亚型特异性PRS风险为1.69倍。
  • FL的亚型特异性PRS风险为2.21倍。
  • MZL的亚型特异性PRS风险为2.26倍。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 需要在犹太人和阿拉伯人群中开展更多GWAS研究以改善这些族群的NHL遗传风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among individuals of European Ancestry (EA), genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) and polygenic risk scores (PRSs) associated with non-Hodgkin lymphoma (NHL) risk. We evaluated subtype-specific PRSs, based on established EA-SNPs, in Israeli Jews (IJ) and Palestinian Arabs (PA) and performed a GWAS in the combined ethnic groups to identify new loci. We included three common pathologically confirmed subtypes: diffuse large B-cell (DLBCL), follicular (FL) and marginal zone (MZL) lymphomas. Controls were frequency matched to cases by age and sex. Among 752 IJ (201-DLBCL; 130-FL; 54-MZL/367-controls) and 593 PA (203-DLBCL; 41-FL/349-controls), we computed PRSs weighted by EA-derived effect estimates and used logistic regression models adjusted for confounders. In the combined ethnic groups of IJ and PA, subtype-specific PRSs were significantly associated with the corresponding subtype, with a 1.69-fold, 2.21-fold and 2.26-fold risk for DLBCL, FL and MZL, respectively; however, these effect sizes were attenuated compared to those reported in EA and varied by ethnicity. In the GWAS of the combined ethnic groups, two novel SNPs in the 6p21.32 locus were associated with DLBCL risk. Additional GWAS studies are needed among Jewish and Arab populations to improve genetic risk prediction for NHL in these ethnic groups.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kleinstern G, Robinson DP, Abu Seir R, et al. European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs. Br J Haematol. 2025. PMID: 40887045. doi:10.1111/bjh.70125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。